SCHEMBL7089170

SCHEMBL7089170

O=C1Oc2ccccc2/C1=C1\Nc2ccccc2C1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.47
MAOB P27338 2/20 0.47
MAPT P10636 4/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
ALDH1A1 P00352 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
LMNA P02545 1/20 0.39
PDGFRA P16234 1/20 0.39
FER P16591 1/20 0.39
LTK P29376 1/20 0.39
CDK8 P49336 1/20 0.39
ACVR1 Q04771 1/20 0.39
LRRK2 Q5S007 1/20 0.39
DYRK1B Q9Y463 1/20 0.39
NQO1 P15559 1/20 0.39
ALOX5 P09917 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7089176 1.00 MAOA (0.47) MAOAMAOBMAPTMEN1KMT2A
SCHEMBL7089174 1.00 MAOA (0.47) MAOAMAOBMAPTMEN1KMT2A
SCHEMBL7092480 0.78 LRRK2 (0.48) MAOAMAOBMAPTMEN1KMT2A
SCHEMBL7092479 0.78 LRRK2 (0.48) MAOAMAOBMAPTMEN1KMT2A
Indigo SCHEMBL42280 0.78 MAOA (0.67) MAOAMAOBMAPTMEN1KMT2A
Indigo SCHEMBL29583322 0.78 MAOA (0.67) MAOAMAOBMAPTMEN1KMT2A
Indigo SCHEMBL320595 0.78 MAOA (0.67) MAOAMAOBMAPTMEN1KMT2A
Indigo SCHEMBL56085 0.78 MAOA (0.67) MAOAMAOBMAPTMEN1KMT2A
Indigo SCHEMBL29829264 0.78 MAOA (0.67) MAOAMAOBMAPTMEN1KMT2A
SCHEMBL7649436 0.75 ALOX15 (0.50) MAOAMAOBMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030121113-A1 Oxobenzofuranylide-dihydroindolone NESVADBA PETER (CH) 2003-07-03 US disclosed
US-6503937-B1 Coloring agents for high molecular weight materials such as polymers CIBA SPECIALTY CHEMICALS CORPORATION 2003-01-07 US disclosed
EP-1123289-B1 OXOBENZOFURANYLIDE-DIHYDROINDOLONES CIBA SC HOLDING AG (CH) 2002-11-27 EP disclosed
EP-1123289-A1 OXOBENZOFURANYLIDE-DIHYDROINDOLONE Ciba SC Holding AG (CH) 2001-08-16 EP disclosed
WO-2000024736-A1 OXOBENZOFURANYLIDE-DIHYDROINDOLONE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030121113-A1 Oxobenzofuranylide-dihydroindolone CYP1B1, CYP1A1, ECI1 MAOA 1624/4885MAOB 561/4885MAPT 4204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.